Downregulation of LXR-α exacerbates renal lipid deposition and kidney damage, according to a prior work by Suto et al., although The reason why LXR agonists work so well is restricted by substantial adverse consequences [17]. This evidence concerns the gene NR1H3 and Nephropathy.